Myomo Signs Agreement With Elevance Health Over Commercial, Medicare Advantage, Medicaid Plans; Expand Myomo's MyoPro Powered Arm And Hand Orthoses

Myomo, Inc. (NYSE:MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, announced today it has entered into its first among a series of expected network participation agreements with Elevance Health. The contracts, which include the Anthem-affiliated Commercial, Medicare Advantage, and Medicaid plans are expected to become effective on a market-by-market basis through the second quarter of 2026. Once complete, the addition of these 45 million medical members will bring Myomo's total number of covered lives under commercial insurance plans to over 80 million.

These agreements are expected to expand access to Myomo's MyoPro® powered arm and hand orthoses, while supporting affordability for plan members and their families on an in-network basis.